ArticlePharmacoEconomics - open2020

Cost-Effectiveness Analysis of Exenatide versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus.

Margarita Capel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.